Records containing: Hypercholesterolaemia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-23Phase 3 Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-0616 in Reducing Major Adverse Cardiovascular Events in Participants at High Cardiovascular Risk
-
CLINICAL_TRIALS study record update · 2026-04-20Specified Drug-use Survey of Leqvio for s.c. Injection (Familial Hypercholesterolaemia or Hypercholesterolaemia, CKJX839A11401)
-
CLINICAL_TRIALS study record update · 2026-04-09A 12-week, Randomised, Double-blinded, Placebo Controlled Study to Evaluate the Efficacy of Lactobacillus Mucosae DPC6426 on Blood-lipids and Cholesterol in Healthy Mildly Hypercholesterolaemic (≥5.5mmol/L and <8 mmol/L) Adults
-
CLINICAL_TRIALS study record update · 2026-03-24A Phase 1 Open-label, Multicenter, First-in-human, Ascending Dose Trial Evaluating the Safety and Tolerability of a Lipid Nanoparticle Formulation of CRISPR-Guide RNA-Cas9 Nuclease (CTX310) for In Vivo Editing of the Angiopoietin-like 3 (ANGPTL3) Gene in Participants With Refractory Dyslipidemias
-
CLINICAL_TRIALS study record update · 2026-01-29Evaluation of Adherence, Persistence and Efficacy of Treatment With Alirocumab 300mg in Italy - The ALINET Registry
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-12-30A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Preliminary Efficacy of Akkermansia Muciniphila AKM Lab-01 in Subjects With Hypercholesterlemia
-
CLINICAL_TRIALS study record update · 2025-12-30Latin America Lipid Optimization After Acute Event in Patients With AthErosclerotic CardiovasculaR DiseaSe and High LDL-C
-
CLINICAL_TRIALS study record update · 2025-09-12Single Dose Oral Bioequivalence Study of Bempedoic Acid 180 mg Film Coated Tablet and Nilemdo® (Bempedoic Acid) 180 mg Film-coated Tablets in Healthy Adult Human Subjects Under Fasting Conditions
-
CLINICAL_TRIALS study record update · 2025-07-16Rosuvastatin Versus Protease Inhibitor Switching for Hypercholesterolaemia in HIV-infected Adults
-
CLINICAL_TRIALS study record update · 2025-05-21Nutritional Intervention Study of the Effect of a Phytosterol-rich Extract on Lipid Profile.
-
CLINICAL_TRIALS study record update · 2025-04-11Single Dose Oral Bioequivalence Study of Bempedoic Acid 180 mg Film Coated Tablet and Nilemdo® (Bempedoic Acid) 180 mg Film-coated Tablets in Healthy Adult Human Subjects Under Fasting Conditions.
-
CLINICAL_TRIALS study record update · 2025-02-28A First-in-Human,Randomized, Double-Blind, Placebo-Controlled, Single Dose Escalation,Phase 1 Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Pharmacodynamics of AK102 in Healthy Subjects
-
CLINICAL_TRIALS study record update · 2025-02-17An Open-Label, Single-Dose Clinical Study to Evaluate the Pharmacokinetics of MK-0616 in Participants With Varying Degrees of Renal Impairment
-
CLINICAL_TRIALS study record update · 2024-08-15Ezetimibe Together With Any Statin Cholesterol Enhancement
-
CLINICAL_TRIALS study record update · 2024-08-15SCH 58235: A Multicenter, Randomised, Parallel Groups, Placebo-Controlled Study Comparing The Efficacy, Safety, and Tolerability Of The Daily Co-Administration of Ezetimibe 10 mg With Simvastatin 20 mg vs Ezetimibe Placebo With Simvastatin 20 mg in Untreated Subjects With Primary Hypercholesterolaemia And Coronary Heart Disease (Protocol P03435)
-
CLINICAL_TRIALS study record update · 2024-06-06Observational Serial Chart Review of Repatha® Use in European Subjects With Hyperlipidaemia
-
CLINICAL_TRIALS study record update · 2023-05-06A Randomized, Double-Blind, Placebo-Controlled Study Followed by an Open Label Treatment Period to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia
-
CLINICAL_TRIALS study record update · 2021-12-30A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of Single Doses of NNC0385-0434 in Healthy Subjects and Patients With Hypercholesterolaemia
-
CLINICAL_TRIALS study record update · 2021-02-18Carotid Atorvastatin Study In Hyperlipidemic Post-Menopausal Women: A Randomized Evaluation of Atorvastatin, Versus Placebo (CASHMERE)
-
CLINICAL_TRIALS study record update · 2020-12-22A Multinational Observational Study to Evaluate the Safety of Repatha® in Pregnancy
-
CLINICAL_TRIALS study record update · 2020-10-20Pharmacokinetic Drug Interaction Study Between Raltegravir and Atorvastatin (AVIATOR).
-
CLINICAL_TRIALS study record update · 2019-09-09A Multicenter, Randomized, Open-label, Parallel-group Usability Study of the Commercial 1 mL Alirocumab Auto-injector Device (AI) and the New 2 mL Auto-injector Device (SYDNEY) in High or Very High Cardiovascular Risk Patients With Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy
-
CLINICAL_TRIALS study record update · 2019-09-06An 8-Week Open-Label, Sequential, Repeated Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia Followed by an Extension Phase
-
CLINICAL_TRIALS study record update · 2018-05-17A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Alirocumab in Insulin Treated Patients With Type 1 or Type 2 Diabetes and With Hypercholesterolemia at High Cardiovascular Risk Not Adequately Controlled on Maximally Tolerated LDL-C Lowering Therapy
-
CLINICAL_TRIALS study record update · 2017-06-20A RANDOMIZED, BALANCED, OPEN LABEL, CROSSOVER, TWO PERIOD, TWO TREATMENT, TWO SEQUENCE, SINGLE DOSE, BIOEQUIVALENCE STUDY OF ACOTRAL® EZETIMIBE 10 MG TABLETS CONTAINING EZETIMIBE MANUFACTURED BY LABORATORIOS PHOENIX S.A.I.C.F, ARGENTINA AND ZETIA® EZETIMIBE 10 MG TABLETS OF MERCK/SCHERING - PLOUGH PHARMACEUTICALS, USA IN HEALTHY ADULT HUMAN MALE SUBJECTS UNDER FASTING CONDITION